BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260908
DTEND;VALUE=DATE:20260913
DTSTAMP:20260330T090524Z
CREATED:20250828T160519Z
LAST-MODIFIED:20260330T090524Z
UID:58781-1788825600-1789257599@www.braincouncil.eu
SUMMARY:34th International Congress of Clinical Neurophysiology (ICCN26)
DESCRIPTION:The International Federation of Clinical Neurophysiology (IFCN)\, in collaboration with their host society the Colombian Association of Electrodiagnostic Medicine (ACME)\, are delighted to welcome you to the 34th International Congress of Clinical Neurophysiology (ICCN 2026)\, taking place in Cartagena\, Colombia\, from 8-12 September 2026. \nThe ICCN is the world’s premier congress for clinical neurophysiology\, bringing together experts from across the globe to share advances in research and clinical practice. The Forum programme is currently being developed by the Scientific Committee\, co-chaired by Professors Tankisi and Guterriez\, with the goal of combining recent research advances with the best clinical teaching to deliver both breadth and depth to the neurophysiology community. \nICCN 2026 will feature an exciting programme of plenary lectures\, scientific symposia\, technical workshops\, educational sessions\, career development opportunities\, and networking events against the stunning backdrop of Cartagena’s rich colonial history and Caribbean charm. This marks the first visit of an ICCN to Colombia\, reflecting the IFCN’s commitment to spreading best practice and education in Clinical Neurophysiology throughout the world. \nDon’t miss the best of Clinical Neurophysiology in this unique and beautiful part of Colombia\, where scientific excellence meets cultural discovery and professional collaboration flourishes into lasting friendships. \nFind out more
URL:https://www.braincouncil.eu/event/iccn2026-congress/
LOCATION:Cartagena\, Colombia
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2025/08/iccn2026-header-image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260908T080000
DTEND;TZID=Europe/Paris:20260908T093000
DTSTAMP:20260727T075852Z
CREATED:20260709T151627Z
LAST-MODIFIED:20260727T075852Z
UID:61245-1788854400-1788859800@www.braincouncil.eu
SUMMARY:Advancing Care Pathways for Ataxia and Rare Neurological Diseases in Europe
DESCRIPTION:Advancing Care Pathways for Ataxia and Rare Neurological Diseases in Europe \n8th of September 2026 | European Parliament \nRare neurological diseases represent a complex and under-recognised challenge for European health systems. These conditions are chronic\, progressive and highly heterogeneous\, requiring timely diagnosis\, specialist expertise and long-term multidisciplinary care. Yet across Europe\, patients still face diagnostic delays\, fragmented referral pathways\, uneven access to specialist centres and insufficient coordination between medical\, rehabilitative and supportive services. \nThe European Brain Council’s Value of Treatment (VOT) project on ataxia\, a rare neurological disorder that causes a loss of control of voluntary muscle coordination\, has generated an important evidence base by demonstrating that patient care pathways matter. These studies found that patients attending specialist ataxia centres reported better understanding of their condition\, more tailored care\, better coordinated referrals and better satisfaction trends than those in non-specialist settings. The accompanying cost analysis showed that\, within countries\, resource use and total costs were broadly similar between specialist and non-specialist settings\, while inpatient stays remained a major contributor to overall costs. The innovation of this work is therefore not only clinical\, but also organisational and policy-relevant: it shows that better coordinated specialist care can improve patient experience and pathway quality without clear evidence of a systematic cost penalty. At the same time\, innovation in ataxia is entering a new phase. Advances in genomics\, biomarkers and emerging therapeutic approaches — including gene replacement\, gene editing\, oligonucleotide and protein-based strategies — are creating new opportunities in hereditary ataxias\, even if major translational and access challenges remain. This makes the need for structured care pathways\, expert centres and coordinated research-ready systems even more urgent\, so that patients can benefit from both current best care and future therapeutic innovation. \nWithin EBC’s Rare Brain Disease Ecosystem (RBDE)\, the ataxia case study forms part of a broader project portfolio aimed at bridging neuroscience\, clinical innovation and patient needs across rare brain conditions. In that sense\, ataxia serves as a strategic entry point for addressing wider challenges shared across rare neurological diseases\, including inequalities in access\, fragmented care\, emerging needs in genomics and health data\, and the need to translate expertise into more coordinated and patient-centred pathways. The challenge is no longer only to document unmet needs\, but to build shared priorities for implementation: how to improve earlier diagnosis\, organise multidisciplinary follow-up\, connect national systems with European expertise\, and ensure that innovation translates into tangible improvements in patients’ lives. Such a meeting is essential to move from evidence generation to actionable policy recommendations and to ensure that future rare neurological disease strategies are informed by clinical expertise\, lived experience and health system realities alike. \nMeeting objective  \nThis invite-only meeting aims to translate the European Brain Council’s Value of Treatment findings on ataxia into concrete scientific and policy priorities for Europe\, while positioning ataxia within the broader Rare Brain Disease Ecosystem. Using ataxia as a strategic case study\, the event will bring together experts\, patient association representatives and policymakers to identify how earlier diagnosis\, specialist multidisciplinary care\, rehabilitation\, patient-centred outcomes and cross-border expertise can be better integrated into care pathways for ataxia and other rare neurological diseases. The goal is to support more coordinated\, equitable and forward-looking care models and to inform the next phase of European action on rare brain diseases. \nAcknowledgement: We would like to thank Biogen for sponsoring this event.
URL:https://www.braincouncil.eu/event/advancing-care-pathways-for-ataxia-and-rare-neurological-diseases-in-europe/
LOCATION:European Parliament\, Rue Wiertz 60\, Brussels\, 1047\, Belgium
CATEGORIES:RBDE
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2026/07/Ataxia-2026-Banner.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260923
DTEND;VALUE=DATE:20260925
DTSTAMP:20260727T102006Z
CREATED:20260519T122108Z
LAST-MODIFIED:20260727T102006Z
UID:60723-1790121600-1790294399@www.braincouncil.eu
SUMMARY:Brain Days at the 81st United Nations General Assembly (UNGA81)
DESCRIPTION:ProgrammeRegister nowBrain disorders — neurological and mental alike — remain among the greatest and fastest-growing challenges facing societies worldwide. Together\, they affect billions of people\, constitute the leading cause of ill health and disability globally\, and exert profound impacts on health systems\, economic resilience\, education\, productivity and social cohesion. As populations age\, demographic and workforce pressures intensify\, and societies navigate rapid technological and social transformation\, the imperative to advance brain health across the life course has never been clearer. Increasingly\, brain health is being recognised not only as a health and research issue\, but as a societal\, economic and development priority central to human capital and sustainable development. \nVenue LocationDisplay a larger mapMomentum is building. In recent years\, brain health has gained growing recognition in global and regional policy agendas — from its increasing visibility within discussions on non-communicable diseases\, to its emergence in debates on neurotechnology\, brain capital and its socioeconomic repercussions on current and future generations. Major developments such as the launch of the European Partnership for Brain Health\, growing discussions on the brain economy at the World Economic Forum and G7/G20 levels\, the expansion of national brain strategies\, and the rise of new global coalitions and research initiatives all point to a field entering a new phase of maturity and ambition. The initiatives and collaborations catalysed during the Brain Days at UNGA80 further reinforced this momentum\, underscoring the value of sustained international dialogue and coordinated action. \nThis growing traction comes at a critical time. The coming years will be decisive in shaping the post-SDG agenda\, the UN’s emerging vision for the future\, and broader global governance frameworks for health\, innovation and sustainable development. It is in this broader context that the Brain Days at UNGA81 will again serve as a platform to bring together policymakers\, scientists\, innovators\, patient advocates\, funders and international organisations to help advance a shared global agenda. Brain Days will take place on 23rd & 24th of September\, 2026\, at Cure. in New York City. Structured around two interconnected pillars\, this year’s event will explore global collaboration in brain health research and innovation — including funding\, science diplomacy and international partnerships — and the broader societal and policy dimensions of brain health\, including brain capital\, prevention\, resilience and pathways towards greater recognition at United Nations level. Building on discussions initiated in previous editions while looking firmly ahead\, the event will aim not only to showcase progress\, but to create a space for active discussion and catalyse concrete next steps for collective action. \nEvent Partners
URL:https://www.braincouncil.eu/event/unga81/
LOCATION:Cure.\, 345 Park Ave S\, New York\, NY\, 10010\, United States
CATEGORIES:Global Partnerships
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2026/05/Website-Banners-1.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260927
DTSTAMP:20260722T093855Z
CREATED:20260709T130714Z
LAST-MODIFIED:20260722T093855Z
UID:61214-1790294400-1790467199@www.braincouncil.eu
SUMMARY:EFNA Conference
DESCRIPTION:The EFNA Conference will take place in Dublin\, Ireland\, on 25-26 September 2026. Organised by the European Federation of Neurological Associations (EFNA)\, the inaugural conference marks a new milestone in the Federation’s 25-year commitment to championing the rights and needs of people living with neurological disorders across Europe. \nHeld during Ireland’s Presidency of the Council of the European Union\, the conference will bring together people living with neurological disorders\, patient organisations\, policymakers\, clinicians\, researchers and industry representatives to co-create a more inclusive and impactful neurology landscape in Europe. \nFurther information on registration\, the scientific programme\, abstract submission and accommodation is available on the official conference website. \nFind out more
URL:https://www.braincouncil.eu/event/efna-2026-conference/
LOCATION:Dublin\, Ireland
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2026/07/Website-Banners.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261005
DTSTAMP:20260716T065941Z
CREATED:20260410T132229Z
LAST-MODIFIED:20260716T065941Z
UID:60594-1790726400-1791158399@www.braincouncil.eu
SUMMARY:EANS 2026 Hamburg Congress
DESCRIPTION:The European Association of Neurosurgical Societies is delighted to welcome you to the EANS Congress 2026\, taking place in Hamburg. \nThe EANS Congress is one of Europe’s leading neurosurgical meetings\, bringing together clinicians\, researchers and healthcare professionals from across the world. Held at the Congress Center Hamburg\, the 2026 edition will take place under the theme “Responsibility\, endurance and resilience”\, reflecting the core values guiding neurosurgical practice\, research and education. \nThe congress will provide a platform for scientific exchange and international collaboration\, while addressing the latest developments in neurosurgery\, including advances in areas such as artificial intelligence\, neurostimulation and personalized approaches to treatment. The Japanese Society for Neurosurgery will join as the first official guest society\, highlighting the global dimension of the meeting. \nFind out morePlenary Session: EANS Alliance in Neurosurgery Symposium \nWednesday\, 30 September 2026 | 09:00 – 11:00 CET | Congress Center Hamburg\, Hall 3 \n  \nRISE Europe Panel Discussion\nFriday\, 2 October 2026 | 14:00 – 15:00 CET | Congress Center Hamburg\, Hall 1 \nEBC President\, Prof. Suzanne Dickson\, will speak on funding in Europe as part of this session led by RISE Europe\, alongside EBC Board Member and FENS Advocacy Committee Chair\, Tomás Ryan\, speaking on EU competitiveness and the European neuroscience research landscape. \nRead More EBC Booth
URL:https://www.braincouncil.eu/event/eans-2026-hamburg-congress/
LOCATION:Hamburg\, Germany
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2026/04/Website-Banners-4.png
END:VEVENT
END:VCALENDAR